Clinical trial · Interventional
Open Versus Laparoscopic Left-sided Hepatectomy Trial
A Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Left-sided Hepatectomy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Open versus Laparoscopic Left-sided Hepatectomy (OLLEH) trial Multi-institutional, prospective and randomized trial in patients undergoing left sided hepatectomy through laparoscopic versus open procedure. Primary endpoint: Functional recovery Secondary endpoint: Hospital duration, estimated blood loss, operation time, resection margin status, postoperative complication, mortality, liver function laboratory test, re-admission, quality of life, cosmesis, cost effectiveness
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm, Liver | Liver Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopic left-sided hepatectomy | Procedure | — | UNRESOLVED |
| Open left-sided hepatectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- A (Open left-sided hepatectomy)
- description
- Open left-sided hepatectomy Laparotomy (upper midline, inverted 'L', or Benz incision) Mobilization of the liver Glissonian approach or individual isolation technique Left lateral sectionectomy or left hemihepatectomy
- interventionNames
- Procedure: Open left-sided hepatectomy
- type
- EXPERIMENTAL
- label
- B (Laparoscopic left-sided hepatectomy)
- description
- Trocar insertion Mobilization of the liver Glissonian approach or individual isolation technique Left lateral sectionectomy or left hemihepatectomy
- interventionNames
- Procedure: Laparoscopic left-sided hepatectomy
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient who underwent open or laparoscopic left-sided hepatectomy for benign or malignant neoplasm of the liver 2. Child-Pugh A without portal hypertension * No portosystemic shunt * No splenomegaly * Platelet count \>100,000/ul 3. Age 18 to 80 4. Eastern Cooperative Oncology Group performance status: 0 or 1 5. American society of anesthesiology class: I or II 6. Informed consent Exclusion Criteria: 1. Additional intervention to the liver (Radio Frequent Ablation, Percutaneous Ethanol. Injection Therapy or others) 2. Combined hepatectomy 3. Bile duct reconstruction 4. Intrahepatic duct stone 5. Upper abdominal laparotomy history 6. Previous hepatectomy 7. Combined operation for extrahepatic disease 8. Vulnerable population (mental retardation, pregnancy) 9. Patient who participated in other clinical trial within 6 months
References
Publications (0)
Data not yet available